Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
- 8 October 1987
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 317 (15) , 909-916
- https://doi.org/10.1056/nejm198710083171501
Abstract
To compare the clinical usefulness of the serum markers prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP), we measured them by radioim-munoassay in 2200 serum samples from 699 patients, 378 of whom had prostatic cancer.This publication has 19 references indexed in Scilit:
- Prostatic Acid Phosphatase: Its Current Clinical StatusJournal of Urology, 1987
- Evaluation of prostate-specific antigen and prosttic acid phosphatase as prostate cancer markersUrology, 1986
- Carcinoma of the Prostate with Atypical Immunohistological FeaturesThe American Journal of Surgical Pathology, 1986
- Human prostate-specific antigen: structural and functional similarity with serine proteases.Proceedings of the National Academy of Sciences, 1986
- PATTERNS OF PROGRESSION IN PROSTATE CANCERThe Lancet, 1986
- A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein.Journal of Clinical Investigation, 1985
- Postcoital Detection of a Male-Specific Semen ProteinNew England Journal of Medicine, 1985
- Serum Prostatic Antigen Measurement in Localized Prostatic Cancer: Correlation with Clinical CourseJournal of Urology, 1982
- Immunohistochemical Identification of Prostatic Acid Phosphatase: Correlation of Tumor Grade with Acid Phosphatase DistributionJournal of Urology, 1982
- Acid PhosphataseUrologic Clinics of North America, 1979